51
|
Hristov DR, Rodriguez-Quijada C, Gomez-Marquez J, Hamad-Schifferli K. Designing Paper-Based Immunoassays for Biomedical Applications. SENSORS (BASEL, SWITZERLAND) 2019; 19:E554. [PMID: 30699964 PMCID: PMC6387326 DOI: 10.3390/s19030554] [Citation(s) in RCA: 65] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/01/2018] [Revised: 01/14/2019] [Accepted: 01/21/2019] [Indexed: 12/18/2022]
Abstract
Paper-based sensors and assays have been highly attractive for numerous biological applications, including rapid diagnostics and assays for disease detection, food safety, and clinical care. In particular, the paper immunoassay has helped drive many applications in global health due to its low cost and simplicity of operation. This review is aimed at examining the fundamentals of the technology, as well as different implementations of paper-based assays and discuss novel strategies for improving their sensitivity, performance, or enabling new capabilities. These innovations can be categorized into using unique nanoparticle materials and structures for detection via different techniques, novel biological species for recognizing biomarkers, or innovative device design and/or architecture.
Collapse
Affiliation(s)
- Delyan R Hristov
- Department of Engineering, University of Massachusetts, Boston, MA 02125, USA.
| | | | - Jose Gomez-Marquez
- Little Devices Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
| | | |
Collapse
|
52
|
Chen J, Zhu Y, Xiong M, Hu G, Zhan J, Li T, Wang L, Wang Y. Antimicrobial Titanium Surface via Click-Immobilization of Peptide and Its in Vitro/Vivo Activity. ACS Biomater Sci Eng 2018; 5:1034-1044. [PMID: 33405794 DOI: 10.1021/acsbiomaterials.8b01046] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The use of antimicrobial peptides (AMPs)-functionalized titanium implants is an efficient method for preventing bacterial infection. However, the attachment of AMPs to the surface of titanium implants remains a challenge. In this study, a "clickable" titanium surface was developed by using a silane coupling agent with an alkynyl group. The antimicrobial titanium implant was then constructed through the reaction between the "clickable" surface and azido-AMPs (PEG-HHC36:N3-PEG12-KRWWKWWRR) via click chemistry of Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC). Such an antimicrobial titanium implant, with an AMP density of 897.4 ± 67.3 ng/cm2 (2.5 ± 0.2 molecules per nm2) on the surface, exhibited good and stable antimicrobial activity, inhibited 90.2% of Staphylococcus aureus and 88.1% of Escherichia coli after 2.5 h of incubation, and even inhibited 69.5% of Staphylococcus aureus after 4 days of degradation. The CCK-8 assay indicated that the antimicrobial titanium implant exhibited negligible cytotoxicity to mouse bone mesenchymal stem cells. In vivo assay illustrated that this implant could kill 78.8% of Staphylococcus aureus after 7 days. This method has great potential for the preparation of antimicrobial titanium implants and the prevention of infections in the clinic.
Collapse
Affiliation(s)
- Junjian Chen
- School of Biomedical Science and Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China.,National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China.,Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, Wushan Road, Tianhe, Guangzhou 510641, China.,Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China
| | - Yuchen Zhu
- Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China
| | - Menghua Xiong
- School of Biomedical Science and Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China
| | - Guansong Hu
- National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China
| | - Jiezhao Zhan
- Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China
| | - Tianjie Li
- School of Biomedical Science and Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China.,Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, Wushan Road, Tianhe, Guangzhou 510641, China
| | - Lin Wang
- School of Biomedical Science and Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China.,Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, Wushan Road, Tianhe, Guangzhou 510641, China
| | - Yingjun Wang
- School of Biomedical Science and Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China.,National Engineering Research Center for Tissue Restoration and Reconstruction, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China.,Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, Wushan Road, Tianhe, Guangzhou 510641, China.,Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Higher Education Mega Center, Panyu, Guangzhou 510006, China
| |
Collapse
|
53
|
Zhang Y, Casabianca LB. Probing Amino Acid Interaction with a Polystyrene Nanoparticle Surface Using Saturation-Transfer Difference (STD)-NMR. J Phys Chem Lett 2018; 9:6921-6925. [PMID: 30480448 DOI: 10.1021/acs.jpclett.8b02785] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
The interaction between individual amino acids and the surface of carboxylate-modified polystyrene nanoparticles in solution was studied using Saturation-Transfer Difference (STD)-Nuclear Magnetic Resonance (NMR). Individual amino acids were screened for nanoparticle binding using an STD-NMR experiment at a fixed saturation time, and STD buildup curves were measured for those amino acids that exhibited significant STD difference signals in the initial screening. The strongest STD effects were measured for protons of aromatic side chains, with relatively weaker effects observed for protons in long-chain aliphatic and positively charged side chains. This indicates that there are several modes of binding to these polystyrene nanoparticles: electrostatic attraction between the negatively charged surface of the carboxylate-modified polystyrene nanoparticle and positively charged amino acids, hydrophobic effects between long aliphatic side chains and the nanoparticle surface, and π-π interactions between aromatic amino acids and aromatic groups in styrene. This information can be used in future studies to predict and understand interactions between nanoparticle surfaces and specific amino acid residues in small peptides and proteins.
Collapse
Affiliation(s)
- Yunzhi Zhang
- Department of Chemistry , Clemson University , Clemson , South Carolina 29634 , United States
| | - Leah B Casabianca
- Department of Chemistry , Clemson University , Clemson , South Carolina 29634 , United States
| |
Collapse
|
54
|
Lara S, Perez-Potti A. Applications of Nanomaterials for Immunosensing. BIOSENSORS-BASEL 2018; 8:bios8040104. [PMID: 30388865 PMCID: PMC6316038 DOI: 10.3390/bios8040104] [Citation(s) in RCA: 33] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/25/2018] [Revised: 10/24/2018] [Accepted: 10/29/2018] [Indexed: 12/28/2022]
Abstract
In biomedical science among several other growing fields, the detection of specific biological agents or biomolecular markers, from biological samples is crucial for early diagnosis and decision-making in terms of appropriate treatment, influencing survival rates. In this regard, immunosensors are based on specific antibody-antigen interactions, forming a stable immune complex. The antigen-specific detection antibodies (i.e., biomolecular recognition element) are generally immobilized on the nanomaterial surfaces and their interaction with the biomolecular markers or antigens produces a physico-chemical response that modulates the signal readout. Lowering the detection limits for particular biomolecules is one of the key parameters when designing immunosensors. Thus, their design by combining the specificity and versatility of antibodies with the intrinsic properties of nanomaterials offers a plethora of opportunities for clinical diagnosis. In this review, we show a comprehensive set of recent developments in the field of nanoimmunosensors and how they are progressing the detection and validation for a wide range of different biomarkers in multiple diseases and what are some drawbacks and considerations of the uses of such devices and their expansion.
Collapse
Affiliation(s)
- Sandra Lara
- Centre for BioNano Interactions, School of Chemistry, University College Dublin, D04 V1W8 Dublin, Ireland.
| | - André Perez-Potti
- Centre for BioNano Interactions, School of Chemistry, University College Dublin, D04 V1W8 Dublin, Ireland.
| |
Collapse
|
55
|
Cloaking nanoparticles with protein corona shield for targeted drug delivery. Nat Commun 2018; 9:4548. [PMID: 30382085 PMCID: PMC6208370 DOI: 10.1038/s41467-018-06979-4] [Citation(s) in RCA: 248] [Impact Index Per Article: 41.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2018] [Accepted: 10/03/2018] [Indexed: 12/11/2022] Open
Abstract
Targeted drug delivery using nanoparticles can minimize the side effects of conventional pharmaceutical agents and enhance their efficacy. However, translating nanoparticle-based agents into clinical applications still remains a challenge due to the difficulty in regulating interactions on the interfaces between nanoparticles and biological systems. Here, we present a targeting strategy for nanoparticles incorporated with a supramolecularly pre-coated recombinant fusion protein in which HER2-binding affibody combines with glutathione-S-transferase. Once thermodynamically stabilized in preferred orientations on the nanoparticles, the adsorbed fusion proteins as a corona minimize interactions with serum proteins to prevent the clearance of nanoparticles by macrophages, while ensuring systematic targeting functions in vitro and in vivo. This study provides insight into the use of the supramolecularly built protein corona shield as a targeting agent through regulating the interfaces between nanoparticles and biological systems.
Collapse
|
56
|
Du Y, Jin J, Jiang W. A study of polyethylene glycol backfilling for enhancing target recognition using QCM-D and DPI. J Mater Chem B 2018; 6:6217-6224. [PMID: 32254612 DOI: 10.1039/c8tb01526k] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
Polyethylene glycol (PEG) is a promising candidate for protein resistance and preserving protein function in biomedical applications. In this study, a PEG-based bifunctional platform with antifouling for plasma proteins and high sensitivity for biomolecules was designed. Long PEG chains (PEG24) were used to install functional biomolecules, and short PEG chains (PEG4) served as a protective layer to backfill the surface and suppress nonspecific protein adsorption. Quartz crystal microbalance with dissipation (QCM-D) and dual polarization interferometry (DPI) were combined to investigate the dynamic process of PEG4 backfilling and the recognition capacity of biomolecules with different ratios of PEG4 and PEG24 in real time. The amount of PEG4 chain backfilling affected the flexibility of PEG24 and exposed sites. The recognition capacity was improved by increasing the ratios of PEG4 to PEG24. Therefore, when the feeding ratio of PEG4 to PEG24 was 9 : 1, a highly efficient and sensitive platform was constructed for immobilization of antibodies and recognition of antigens either in pure PBS or in a complex biological environment.
Collapse
Affiliation(s)
- Yanqiu Du
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China.
| | | | | |
Collapse
|
57
|
Cui J, Björnmalm M, Ju Y, Caruso F. Nanoengineering of Poly(ethylene glycol) Particles for Stealth and Targeting. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2018; 34:10817-10827. [PMID: 30132674 DOI: 10.1021/acs.langmuir.8b02117] [Citation(s) in RCA: 44] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The assembly of particles composed solely or mainly of poly(ethylene glycol) (PEG) is an emerging area that is gaining increasing interest within bio-nano science. PEG, widely considered to be the "gold standard" among polymers for drug delivery, is providing a platform for exploring fundamental questions and phenomena at the interface between particle engineering and biomedicine. These include the targeting and stealth behaviors of synthetic nanomaterials in biological environments. In this feature article, we discuss recent work in the nanoengineering of PEG particles and explore how they are enabling improved targeting and stealth performance. Specific examples include PEG particles prepared through surface-initiated polymerization, mesoporous silica replication via postinfiltration, and particle assembly through metal-phenolic coordination. This particle class exhibits unique in vivo behavior (e.g., biodistribution and immune cell interactions) and has recently been explored for drug delivery applications.
Collapse
Affiliation(s)
- Jiwei Cui
- Key Laboratory of Colloid and Interface Chemistry of the Ministry of Education, and the School of Chemistry and Chemical Engineering , Shandong University , Jinan , Shandong 250100 , China
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| | - Mattias Björnmalm
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
- Department of Materials, Department of Bioengineering, and Institute of Biomedical Engineering , Imperial College London , London SW7 2AZ , United Kingdom
| | - Yi Ju
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and the Department of Chemical Engineering , The University of Melbourne , Parkville , Victoria 3010 , Australia
| |
Collapse
|
58
|
Faria M, Björnmalm M, Thurecht KJ, Kent SJ, Parton RG, Kavallaris M, Johnston APR, Gooding JJ, Corrie SR, Boyd BJ, Thordarson P, Whittaker AK, Stevens MM, Prestidge CA, Porter CJH, Parak WJ, Davis TP, Crampin EJ, Caruso F. Minimum information reporting in bio-nano experimental literature. NATURE NANOTECHNOLOGY 2018; 13:777-785. [PMID: 30190620 PMCID: PMC6150419 DOI: 10.1038/s41565-018-0246-4] [Citation(s) in RCA: 377] [Impact Index Per Article: 62.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/06/2018] [Accepted: 07/24/2018] [Indexed: 04/14/2023]
Abstract
Studying the interactions between nanoengineered materials and biological systems plays a vital role in the development of biological applications of nanotechnology and the improvement of our fundamental understanding of the bio-nano interface. A significant barrier to progress in this multidisciplinary area is the variability of published literature with regards to characterizations performed and experimental details reported. Here, we suggest a 'minimum information standard' for experimental literature investigating bio-nano interactions. This standard consists of specific components to be reported, divided into three categories: material characterization, biological characterization and details of experimental protocols. Our intention is for these proposed standards to improve reproducibility, increase quantitative comparisons of bio-nano materials, and facilitate meta analyses and in silico modelling.
Collapse
Affiliation(s)
- Matthew Faria
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, Australia
- Systems Biology Laboratory, School of Mathematics and Statistics and Melbourne School of Engineering, The University of Melbourne, Parkville, Victoria, Australia
| | - Mattias Björnmalm
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, Australia
- Department of Materials, Imperial College London, London, UK
- Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London, UK
| | - Kristofer J Thurecht
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
- Centre for Advanced Imaging, The University of Queensland, Brisbane, Queensland, Australia
| | - Stephen J Kent
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Department of Microbiology and Immunology, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia
| | - Robert G Parton
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
- Centre for Microscopy and Microanalysis, University of Queensland, Brisbane, Queensland, Australia
| | - Maria Kavallaris
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Tumour Biology and Targeting Program, Children's Cancer Institute, Lowy Cancer Research Centre, The University of New South Wales, Sydney, New South Wales, Australia
- School of Chemistry, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, New South Wales, Australia
| | - Angus P R Johnston
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia
| | - J Justin Gooding
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- School of Chemistry, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, New South Wales, Australia
| | - Simon R Corrie
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
- Department of Chemical Engineering, Monash University, Clayton, Victoria, Australia
| | - Ben J Boyd
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia
| | - Pall Thordarson
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- School of Chemistry, Australian Centre for NanoMedicine, The University of New South Wales, Sydney, New South Wales, Australia
| | - Andrew K Whittaker
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
| | - Molly M Stevens
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Department of Materials, Imperial College London, London, UK
- Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, London, UK
| | - Clive A Prestidge
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- School of Pharmacy and Medical Science, The University of South Australia, Adelaide, South Australia, Australia
| | - Christopher J H Porter
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia
| | - Wolfgang J Parak
- Fachbereich Physik und Chemie, CHyN, Universität Hamburg, Hamburg, Germany
- Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Diagnosis and Treatment Instrument, Key Laboratory for Thin Film and Microfabrication Technology of the Ministry of Education, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, China
| | - Thomas P Davis
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia
- Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia
- Department of Chemistry, University of Warwick, Coventry, UK
| | - Edmund J Crampin
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia, .
- Systems Biology Laboratory, School of Mathematics and Statistics and Melbourne School of Engineering, The University of Melbourne, Parkville, Victoria, Australia.
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Australia, .
- Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria, Australia.
| |
Collapse
|
59
|
Tonigold M, Simon J, Estupiñán D, Kokkinopoulou M, Reinholz J, Kintzel U, Kaltbeitzel A, Renz P, Domogalla MP, Steinbrink K, Lieberwirth I, Crespy D, Landfester K, Mailänder V. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona. NATURE NANOTECHNOLOGY 2018; 13:862-869. [PMID: 29915272 DOI: 10.1038/s41565-018-0171-6] [Citation(s) in RCA: 184] [Impact Index Per Article: 30.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/23/2017] [Accepted: 05/21/2018] [Indexed: 05/17/2023]
Abstract
To promote drug delivery to exact sites and cell types, the surface of nanocarriers is functionalized with targeting antibodies or ligands, typically coupled by covalent chemistry. Once the nanocarrier is exposed to biological fluid such as plasma, however, its surface is inevitably covered with various biomolecules forming the protein corona, which masks the targeting ability of the nanoparticle. Here, we show that we can use a pre-adsorption process to attach targeting antibodies to the surface of the nanocarrier. Pre-adsorbed antibodies remain functional and are not completely exchanged or covered by the biomolecular corona, whereas coupled antibodies are more affected by this shielding. We conclude that pre-adsorption is potentially a versatile, efficient and rapid method of attaching targeting moieties to the surface of nanocarriers.
Collapse
Affiliation(s)
- Manuel Tonigold
- Dermatology Clinic, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
- Max Planck Institute for Polymer Research, Mainz, Germany
| | - Johanna Simon
- Dermatology Clinic, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
- Max Planck Institute for Polymer Research, Mainz, Germany
| | | | | | - Jonas Reinholz
- Dermatology Clinic, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
- Max Planck Institute for Polymer Research, Mainz, Germany
| | - Ulrike Kintzel
- Dermatology Clinic, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
- Max Planck Institute for Polymer Research, Mainz, Germany
| | | | - Patricia Renz
- Max Planck Institute for Polymer Research, Mainz, Germany
| | - Matthias P Domogalla
- Dermatology Clinic, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
| | - Kerstin Steinbrink
- Dermatology Clinic, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
| | | | - Daniel Crespy
- Max Planck Institute for Polymer Research, Mainz, Germany
| | | | - Volker Mailänder
- Dermatology Clinic, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
- Max Planck Institute for Polymer Research, Mainz, Germany.
| |
Collapse
|
60
|
Abstract
The conjugation of biomolecules can impart materials with the bioactivity necessary to modulate specific cell behaviors. While the biological roles of particular polypeptide, oligonucleotide, and glycan structures have been extensively reviewed, along with the influence of attachment on material structure and function, the key role played by the conjugation strategy in determining activity is often overlooked. In this review, we focus on the chemistry of biomolecule conjugation and provide a comprehensive overview of the key strategies for achieving controlled biomaterial functionalization. No universal method exists to provide optimal attachment, and here we will discuss both the relative advantages and disadvantages of each technique. In doing so, we highlight the importance of carefully considering the impact and suitability of a particular technique during biomaterial design.
Collapse
Affiliation(s)
- Christopher D. Spicer
- Department
of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles Väg 2, Stockholm, Sweden
| | - E. Thomas Pashuck
- NJ
Centre for Biomaterials, Rutgers University, 145 Bevier Road, Piscataway, New Jersey United States
| | - Molly M. Stevens
- Department
of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles Väg 2, Stockholm, Sweden
- Department
of Materials, Department of Bioengineering, and Institute of Biomedical Engineering, Imperial College London, Exhibition Road, London, United Kingdom
| |
Collapse
|
61
|
Lara S, Perez-Potti A, Herda LM, Adumeau L, Dawson KA, Yan Y. Differential Recognition of Nanoparticle Protein Corona and Modified Low-Density Lipoprotein by Macrophage Receptor with Collagenous Structure. ACS NANO 2018; 12:4930-4937. [PMID: 29668255 DOI: 10.1021/acsnano.8b02014] [Citation(s) in RCA: 57] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Key practical challenges such as understanding the immunological processes at the nanoscale and controlling the targeting and accumulation of nano-objects in vivo now further stimulate efforts to underpin phenomenological knowledge of the nanoscale with more mechanistic and molecular insight. Thus, the question as to what constitutes nanoscale biological identity continues to evolve. Certainly nanoparticles in contact with a complex biological milieu develop a biological identity, differing from the original nanomaterial, now referred to as the "biomolecular corona". However, this surface-adsorbed layer of biomolecules may in some circumstance lead to different forms of receptor-particle interactions not evident only from the identity of the surface-adsorbed biomolecules and hard to predict or detect by current physicochemical methods. Here we show that scavenger receptors may recognize complex as yet unidentified biomolecular surface layer motifs, even when no current physicochemical analysis is capable of doing so. For instance, fluorescently labeled SiO2 nanoparticles in a biological milieu are strongly recognized by the macrophage receptor with collagenous structure (MARCO) in even dense biological media (human serum) apparently using a form of binding with which most of the MARCO's known ligands ( e. g., LPS, modified LDL) fail to compete. Such observations may suggest the need for a much stronger emphasis on nanoscale receptor-corona and other biomolecular interaction studies if one wishes to unravel how biomolecular recognition drives outcomes in the nanoscale biological domain.
Collapse
Affiliation(s)
- Sandra Lara
- Centre for BioNano Interactions, School of Chemistry , University College Dublin , Belfield, Dublin 4 , Ireland
| | - André Perez-Potti
- Centre for BioNano Interactions, School of Chemistry , University College Dublin , Belfield, Dublin 4 , Ireland
| | - Luciana M Herda
- Centre for BioNano Interactions, School of Chemistry , University College Dublin , Belfield, Dublin 4 , Ireland
| | - Laurent Adumeau
- Centre for BioNano Interactions, School of Chemistry , University College Dublin , Belfield, Dublin 4 , Ireland
| | - Kenneth A Dawson
- Centre for BioNano Interactions, School of Chemistry , University College Dublin , Belfield, Dublin 4 , Ireland
| | - Yan Yan
- Centre for BioNano Interactions, School of Chemistry , University College Dublin , Belfield, Dublin 4 , Ireland
- UCD Conway Institute of Biomolecular and Biomedical Research, School of Biomolecular and Biomedical Science , University College Dublin , Belfield, Dublin 4 , Ireland
| |
Collapse
|
62
|
Spicer CD, Jumeaux C, Gupta B, Stevens MM. Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications. Chem Soc Rev 2018; 47:3574-3620. [PMID: 29479622 PMCID: PMC6386136 DOI: 10.1039/c7cs00877e] [Citation(s) in RCA: 272] [Impact Index Per Article: 45.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Peptide- and protein-nanoparticle conjugates have emerged as powerful tools for biomedical applications, enabling the treatment, diagnosis, and prevention of disease. In this review, we focus on the key roles played by peptides and proteins in improving, controlling, and defining the performance of nanotechnologies. Within this framework, we provide a comprehensive overview of the key sequences and structures utilised to provide biological and physical stability to nano-constructs, direct particles to their target and influence their cellular and tissue distribution, induce and control biological responses, and form polypeptide self-assembled nanoparticles. In doing so, we highlight the great advances made by the field, as well as the challenges still faced in achieving the clinical translation of peptide- and protein-functionalised nano-drug delivery vehicles, imaging species, and active therapeutics.
Collapse
Affiliation(s)
- Christopher D Spicer
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles Väg 2, Stockholm, Sweden.
| | | | | | | |
Collapse
|
63
|
Abstract
The systematic study of nanoparticle-biological interactions requires particles to be reproducibly dispersed in relevant fluids along with further development in the identification of biologically relevant structural details at the materials-biology interface. Here, we develop a biocompatible long-term colloidally stable water dispersion of few-layered graphene nanoflakes in the biological exposure medium in which it will be studied. We also report the study of the orientation and functionality of key proteins of interest in the biolayer (corona) that are believed to mediate most of the early biological interactions. The evidence accumulated shows that graphene nanoflakes are rich in effective apolipoprotein A-I presentation, and we are able to map specific functional epitopes located in the C-terminal portion that are known to mediate the binding of high-density lipoprotein to binding sites in receptors that are abundant in the liver. This could suggest a way of connecting the materials' properties to the biological outcomes.
Collapse
|
64
|
Gianneli M, Polo E, Lopez H, Castagnola V, Aastrup T, Dawson KA. Label-free in-flow detection of receptor recognition motifs on the biomolecular corona of nanoparticles. NANOSCALE 2018; 10:5474-5481. [PMID: 29511756 DOI: 10.1039/c7nr07887k] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Nanomedicine, nanotargeting and nanotherapeutics have in the last few years faced several difficulties in translating the promising results obtained in vitro to an in vivo scenario. The origin of this discrepancy might be found in the lack of a detailed and realistic characterization of the biological surface of nanoparticles. Despite the capability to engineer nanomaterials with a great variety and a precise control of the surface functionalization, the targeting capability is lost when the nanoparticles are embedded in complex biological media, due to the formation of a biological layer (biomolecular corona). This biological layer represents the ultimate nanoparticle surface, likely to interact with the cell machinery. Therefore, in addition to traditional nanoparticle characterization techniques, a more insightful investigation of the biomolecular corona is needed, including the capability to assess the orientation and functionality of specific key molecular features. Here we present a method for the rapid screening of exposed protein recognition motifs on the surface of nanoparticles exploiting quartz crystal microbalance (QCM). We quantify accessible functional epitopes of transferrin-coated nanoparticles and correlate them to differences in nanoparticle size and functionalization. The target recognition occurs label free in flow, thereby pushing our investigation into a more in vivo-like scenario. Our method is applicable to a wide array of nanoparticles and therefore holds the potential to become an advanced technique for the classification of all kinds of nanobioconstructs based on their biological external functionality.
Collapse
Affiliation(s)
- M Gianneli
- Attana AB, Greta Arwidssons Väg 21, SE-11419 Stockholm, Sweden
| | - E Polo
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Dublin, Ireland.
| | - H Lopez
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Dublin, Ireland.
| | - V Castagnola
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Dublin, Ireland.
| | - T Aastrup
- Attana AB, Greta Arwidssons Väg 21, SE-11419 Stockholm, Sweden
| | - K A Dawson
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Dublin, Ireland.
| |
Collapse
|
65
|
Caracciolo G. Clinically approved liposomal nanomedicines: lessons learned from the biomolecular corona. NANOSCALE 2018; 10:4167-4172. [PMID: 29450412 DOI: 10.1039/c7nr07450f] [Citation(s) in RCA: 53] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
Nowadays, liposomes are the most successful drug delivery systems with a dozen drug products available in the clinic. Grafting poly-(ethylene glycol) (PEG) onto the liposome surface prevents protein binding thus prolonging blood circulation, while synthetic modification of the terminal PEG molecule with ligands (e.g. monoclonal antibodies and peptides) should promote selective accumulation in the tumor region with respect to healthy tissues. However, despite big efforts, advances have not outgrown the development stage and just a few targeted liposomal drugs are commercially available. The latest studies have clarified that following exposure to physiological environments liposomes are covered by a biomolecular corona (BC). Main factors shaping the BC are the liposomes' physicochemical properties (i.e. size, surface charge and lipid composition), the biological fluid (e.g. plasma of healthy volunteers vs. plasma of cancer patients) and environmental factors (e.g. temperature). Combining the most recent evidence reported in the literature, herein we suggest that the liposome-BC could act as a personalized "endogenous trigger" affecting off-target interactions and controlling the indication for disease of clinically approved formulations. In this Opinion paper, we suggest that a better understanding of the liposome-BC together with improvements in mapping corona proteins will open the fascinating possibility to manipulate the BC by liposome design. This is not an easy task, but it could represent a turning point in the development of novel liposome-based targeting strategies for personalized nanomedicines.
Collapse
Affiliation(s)
- Giulio Caracciolo
- Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 291, 00161, Rome, Italy.
| |
Collapse
|
66
|
Li Z, Li D, Li Q, Luo C, Li J, Kou L, Zhang D, Zhang H, Zhao S, Kan Q, Liu J, Zhang P, Liu X, Sun Y, Wang Y, He Z, Sun J. In situlow-immunogenic albumin-conjugating-corona guiding nanoparticles for tumor-targeting chemotherapy. Biomater Sci 2018; 6:2681-2693. [DOI: 10.1039/c8bm00692j] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Thein siturecruited albumin corona enables NPs' tumor-targeting and enhanced antitumor activityin vivo.
Collapse
|
67
|
Dai Q, Bertleff‐Zieschang N, Braunger JA, Björnmalm M, Cortez‐Jugo C, Caruso F. Particle Targeting in Complex Biological Media. Adv Healthc Mater 2018; 7. [PMID: 28809092 DOI: 10.1002/adhm.201700575] [Citation(s) in RCA: 72] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Revised: 06/04/2017] [Indexed: 12/22/2022]
Abstract
Over the past few decades, nanoengineered particles have gained increasing interest for applications in the biomedical realm, including diagnosis, imaging, and therapy. When functionalized with targeting ligands, these particles have the potential to interact with specific cells and tissues, and accumulate at desired target sites, reducing side effects and improve overall efficacy in applications such as vaccination and drug delivery. However, when targeted particles enter a complex biological environment, the adsorption of biomolecules and the formation of a surface coating (e.g., a protein corona) changes the properties of the carriers and can render their behavior unpredictable. For this reason, it is of importance to consider the potential challenges imposed by the biological environment at the early stages of particle design. This review describes parameters that affect the targeting ability of particulate drug carriers, with an emphasis on the effect of the protein corona. We highlight strategies for exploiting the protein corona to improve the targeting ability of particles. Finally, we provide suggestions for complementing current in vitro assays used for the evaluation of targeting and carrier efficacy with new and emerging techniques (e.g., 3D models and flow-based technologies) to advance fundamental understanding in bio-nano science and to accelerate the development of targeted particles for biomedical applications.
Collapse
Affiliation(s)
- Qiong Dai
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering The University of Melbourne Parkville Victoria 3010 Australia
| | - Nadja Bertleff‐Zieschang
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering The University of Melbourne Parkville Victoria 3010 Australia
| | - Julia A. Braunger
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering The University of Melbourne Parkville Victoria 3010 Australia
| | - Mattias Björnmalm
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering The University of Melbourne Parkville Victoria 3010 Australia
| | - Christina Cortez‐Jugo
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering The University of Melbourne Parkville Victoria 3010 Australia
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio‐Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering The University of Melbourne Parkville Victoria 3010 Australia
| |
Collapse
|
68
|
Fan JX, Zheng DW, Mei WW, Chen S, Chen SY, Cheng SX, Zhang XZ. A Metal-Polyphenol Network Coated Nanotheranostic System for Metastatic Tumor Treatments. SMALL (WEINHEIM AN DER BERGSTRASSE, GERMANY) 2017; 13:1702714. [PMID: 29125688 DOI: 10.1002/smll.201702714] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/07/2017] [Revised: 09/14/2017] [Indexed: 06/07/2023]
Abstract
As a characteristic trait of most tumor types, metastasis is the major cause of the death of patients. In this study, a photothermal agent based on gold nanorod is coated with metal (Gd3+ )-organic (polyphenol) network to realize combination therapy for metastatic tumors. This nanotheranostic system significantly enhances antitumor therapeutic effects in vitro and in vivo with the combination of photothermal therapy (PTT) and chemotherapy, also can remarkably prevent the invasion and metastasis due to the presence of polyphenol. After the treatment, an 81% decrease in primary tumor volumes and a 58% decrease in lung metastasis are observed. In addition, the good performance in magnetic resonance imaging, computerized tomography, and photothermal imaging of the nanotheranostic system can realize image-guided therapy. The multifunctional nanotheranostic system will find a great potential in diagnosis and treatment integration in tumor treatments, and broaden the applications of PTT treatment.
Collapse
Affiliation(s)
- Jin-Xuan Fan
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China
| | - Di-Wei Zheng
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China
| | - Wen-Wen Mei
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China
| | - Si Chen
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China
| | - Si-Yi Chen
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China
| | - Si-Xue Cheng
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China
| | - Xian-Zheng Zhang
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China
- The Institute for Advanced Studies, Wuhan University, Wuhan, 430072, P. R. China
| |
Collapse
|
69
|
Li M, Dang D, Xi N, Wang Y, Liu L. Nanoscale imaging and force probing of biomolecular systems using atomic force microscopy: from single molecules to living cells. NANOSCALE 2017; 9:17643-17666. [PMID: 29135007 DOI: 10.1039/c7nr07023c] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Due to the lack of adequate tools for observation, native molecular behaviors at the nanoscale have been poorly understood. The advent of atomic force microscopy (AFM) provides an exciting instrument for investigating physiological processes on individual living cells with molecular resolution, which attracts the attention of worldwide researchers. In the past few decades, AFM has been widely utilized to investigate molecular activities on diverse biological interfaces, and the performances and functions of AFM have also been continuously improved, greatly improving our understanding of the behaviors of single molecules in action and demonstrating the important role of AFM in addressing biological issues with unprecedented spatiotemporal resolution. In this article, we review the related techniques and recent progress about applying AFM to characterize biomolecular systems in situ from single molecules to living cells. The challenges and future directions are also discussed.
Collapse
Affiliation(s)
- Mi Li
- State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang 110016, China.
| | | | | | | | | |
Collapse
|
70
|
Björnmalm M, Thurecht KJ, Michael M, Scott AM, Caruso F. Bridging Bio-Nano Science and Cancer Nanomedicine. ACS NANO 2017; 11:9594-9613. [PMID: 28926225 DOI: 10.1021/acsnano.7b04855] [Citation(s) in RCA: 237] [Impact Index Per Article: 33.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
The interface of bio-nano science and cancer medicine is an area experiencing much progress but also beset with controversy. Core concepts of the field-e.g., the enhanced permeability and retention (EPR) effect, tumor targeting and accumulation, and even the purpose of "nano" in cancer medicine-are hotly debated. In parallel, considerable advances in neighboring fields are occurring rapidly, including the recent progress of "immuno-oncology" and the fundamental impact it is having on our understanding and the clinical treatment of the group of diseases collectively known as cancer. Herein, we (i) revisit how cancer is commonly treated in the clinic and how this relates to nanomedicine; (ii) examine the ongoing debate on the relevance of the EPR effect and tumor targeting; (iii) highlight ways to improve the next-generation of nanomedicines; and (iv) discuss the emerging concept of working with (and not against) biology. While discussing these controversies, challenges, emerging concepts, and opportunities, we explore new directions for the field of cancer nanomedicine.
Collapse
Affiliation(s)
- Mattias Björnmalm
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| | - Kristofer J Thurecht
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, The Australian Institute for Bioengineering and Nanotechnology and The Centre for Advanced Imaging, The University of Queensland , Brisbane, Queensland 4072, Australia
| | - Michael Michael
- Division of Cancer Medicine, Peter MacCallum Cancer Centre , Melbourne, Victoria 3000, Australia
- The Peter MacCallum Department of Oncology, The University of Melbourne , Parkville, Victoria 3010, Australia
| | - Andrew M Scott
- Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University , Melbourne, Victoria 3084, Australia
- Department of Molecular Imaging and Therapy, Austin Hospital , Heidelberg, Victoria 3084, Australia
| | - Frank Caruso
- ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia
| |
Collapse
|
71
|
Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System. Semin Immunol 2017; 34:52-60. [PMID: 29066063 DOI: 10.1016/j.smim.2017.10.001] [Citation(s) in RCA: 152] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/27/2017] [Revised: 09/29/2017] [Accepted: 10/03/2017] [Indexed: 11/21/2022]
Abstract
The interaction of inorganic nanoparticles and many biological fluids often withstands the formation of a Protein Corona enveloping the nanoparticle. This Protein Corona provides the biological identity to the nanoparticle that the immune system will detect. The formation of this Protein Corona depends not only on the composition of the nanoparticle, its size, shape, surface state and exposure time, but also on the type of media, nanoparticle to protein ratio and the presence of ions and other molecular species that interfere in the interaction between proteins and nanoparticles. This has important implications on immune safety, biocompatibility and the use of nanoparticles in medicine.
Collapse
|
72
|
Florek J, Caillard R, Kleitz F. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers. NANOSCALE 2017; 9:15252-15277. [PMID: 28984885 DOI: 10.1039/c7nr05762h] [Citation(s) in RCA: 124] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
The oral pathway is considered as the most common method for drug administration, although many drugs, especially the highly pH- and/or enzymatic biodegradable peptide drugs, are very difficult to formulate and achieve a good intestinal absorption. Efficient systematic absorption of an active substance, delivered via oral ingestion, is only achievable if the drug (1) is substantially present as a solution in the gastrointestinal tract, (2) is able to penetrate through the intestinal mucus, (3) overcomes the different gastrointestinal barriers, and (4) provides an effective therapeutic dose. Therefore, optimization of oral bioavailability of poorly-soluble drugs still remains a significant challenge for the pharmaceutical industry. Even though numerous conventional drug carriers have successfully solved some of the issues related to oral delivery of poorly-soluble drugs, only few of them met commercialization requirements. These drawbacks have led the scientific world to reconsider its approaches toward targeted drug delivery systems and researchers started looking for alternative vectorized carriers. In this area, nanoparticle-based materials have several significant advantages over free and non-formulated drugs. For example, nanosized porous silica carriers allow for more sustained and controlled drug release or improved oral bioavailability. Thus, in the present review, we will highlight the most important features of nanostructured silica drug carriers, such as particle size, particle shape, surface roughness or surface functionalization, and underline the key advantages of these nanosupports. In particular, this article will discuss recent progress and challenges in the area of mesoporous silica nanocarriers used for oral drug delivery. Additional emphasis will be set on the biological and chemical features of the gastrointestinal tract as well as currently tested nanoformulations and strategies to avoid drug degradation in the gastrointestinal environment.
Collapse
Affiliation(s)
- Justyna Florek
- Department of Inorganic Chemistry - Functional Materials, Faculty of Chemistry, University of Vienna, Währinger Str. 42, 1090 Vienna, Austria.
| | | | | |
Collapse
|
73
|
Ribeiro AR, Mukherjee A, Hu X, Shafien S, Ghodsi R, He K, Gemini-Piperni S, Wang C, Klie RF, Shokuhfar T, Shahbazian-Yassar R, Borojevic R, Rocha LA, Granjeiro JM. Bio-camouflage of anatase nanoparticles explored by in situ high-resolution electron microscopy. NANOSCALE 2017; 9:10684-10693. [PMID: 28654127 DOI: 10.1039/c7nr02239e] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
While titanium is the metal of choice for most prosthetics and inner body devices due to its superior biocompatibility, the discovery of Ti-containing species in the adjacent tissue as a result of wear and corrosion has been associated with autoimmune diseases and premature implant failures. Here, we utilize the in situ liquid cell transmission electron microscopy (TEM) in a liquid flow holder and graphene liquid cells (GLCs) to investigate, for the first time, the in situ nano-bio interactions between titanium dioxide nanoparticles and biological medium. This imaging and spectroscopy methodology showed the process of formation of an ionic and proteic bio-camouflage surrounding Ti dioxide (anatase) nanoparticles that facilitates their internalization by bone cells. The in situ understanding of the mechanisms of the formation of the bio-camouflage of anatase nanoparticles may contribute to the definition of strategies aimed at the manipulation of these NPs for bone regenerative purposes.
Collapse
Affiliation(s)
- Ana R Ribeiro
- Directory of Life Sciences Applied Metrology, National Institute of Metrology Quality and Technology, Rio de Janeiro, Brazil.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
74
|
Papi M, Caputo D, Palmieri V, Coppola R, Palchetti S, Bugli F, Martini C, Digiacomo L, Pozzi D, Caracciolo G. Clinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cells. NANOSCALE 2017; 9:10327-10334. [PMID: 28702661 DOI: 10.1039/c7nr03042h] [Citation(s) in RCA: 53] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Today, liposomes are an advanced technology of drug carriers with a dozen drugs in clinical practice and many more in clinical trials. A bottleneck associated with the clinical translation of liposomes has long been 'opsonization', i.e. the adsorption of plasma proteins at the liposome surface resulting in their rapid clearance from circulation. For decades, the most popular way to avoid opsonization has been grafting polyethylene glycol (PEG) onto the liposome surface. Recent studies have clarified that grafting PEG onto the liposome surface reduces, but does not completely prevent protein binding. In this work, we employed dynamic light scattering, zeta-potential analysis, one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (1D-SDS-PAGE), semi-quantitative densitometry and cell imaging to explore the bio-nano-interactions between human plasma (HP) and Onivyde, a PEGylated liposomal drug that has recently been approved by the Food and Drug Administration (FDA) for the treatment of metastatic pancreatic ductal adenocarcinoma (PDAC). To properly evaluate the role of PEGylation, an unPEGylated variant of Onivyde was used as a reference. Collectively, our findings suggest that: (i) although PEGylated, Onivyde is not "stealth" in HP; (ii) surface chemistry is more important than PEGylation in controlling the bio-nano-interactions between Onivyde and plasma components. Of note is that the PC was found to boost the cellular uptake of Onivyde in the pancreas ductal adenocarcinoma cell line (PANC-1) thus suggesting its prominent role in its indication for PDAC treatment. Relevant implications for drug delivery and drug design are discussed.
Collapse
Affiliation(s)
- M Papi
- Istituto di Fisica, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy
| | - D Caputo
- University Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, 00128 Rome, Italy
| | - V Palmieri
- Istituto di Fisica, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy
| | - R Coppola
- University Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, 00128 Rome, Italy
| | - S Palchetti
- Department of Molecular Medicine, "Sapienza" University of Rome, Viale Regina Elena 291, 00161 Rome, Italy. and Istituti Fisioterapici Ospitalieri, Istituto Regina Elena, Via Elio Chianesi 53, 00144 Rome, Italy
| | - F Bugli
- Istituto di Microbiologia, Universitá Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy
| | - C Martini
- Istituto di Microbiologia, Universitá Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy
| | - L Digiacomo
- Department of Molecular Medicine, "Sapienza" University of Rome, Viale Regina Elena 291, 00161 Rome, Italy. and Department of Bioscience and Biotechnology, University of Camerino, Via Gentile III da Varano, 62032 Camerino, MC, Italy
| | - D Pozzi
- Department of Molecular Medicine, "Sapienza" University of Rome, Viale Regina Elena 291, 00161 Rome, Italy. and Istituti Fisioterapici Ospitalieri, Istituto Regina Elena, Via Elio Chianesi 53, 00144 Rome, Italy
| | - G Caracciolo
- Department of Molecular Medicine, "Sapienza" University of Rome, Viale Regina Elena 291, 00161 Rome, Italy.
| |
Collapse
|
75
|
Betzer O, Shilo M, Opochinsky R, Barnoy E, Motiei M, Okun E, Yadid G, Popovtzer R. The effect of nanoparticle size on the ability to cross the blood-brain barrier: an in vivo study. Nanomedicine (Lond) 2017. [PMID: 28621578 DOI: 10.2217/nnm-2017-0022] [Citation(s) in RCA: 167] [Impact Index Per Article: 23.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
AIM Our goal was to develop an efficient nanoparticle-based system that can overcome the restrictive mechanism of the blood-brain barrier (BBB) by targeting insulin receptors and would thus enable drug delivery to the brain. METHODS Insulin-coated gold nanoparticles (INS-GNPs) were synthesized to serve as a BBB transport system. The effect of nanoparticle size (20, 50 and 70 nm) on their ability to cross the BBB was quantitatively investigated in Balb/C mice. RESULTS The most widespread biodistribution and highest accumulation within the brain were observed using 20 nm INS-GNPs, 2 h post injection. In vivo CT imaging revealed that particles migrated to specific brain regions, which are involved in neurodegenerative and neuropsychiatric disorders. CONCLUSION These findings promote the optimization of nanovehicles for transport of drugs through the BBB. The insulin coating of the particles enabled targeting of specific brain regions, suggesting the potential use of INS-GNPs for delivery of various treatments for brain-related disorders.
Collapse
Affiliation(s)
- Oshra Betzer
- Faculty of Engineering & the Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel.,The Leslie & Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel
| | - Malka Shilo
- Faculty of Engineering & the Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel
| | - Renana Opochinsky
- Faculty of Engineering & the Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel
| | - Eran Barnoy
- Faculty of Engineering & the Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel
| | - Menachem Motiei
- Faculty of Engineering & the Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel
| | - Eitan Okun
- The Leslie & Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel.,The Mina & Everard Goodman Faculty of Life sciences, Bar-Ilan University, Ramat Gan 5290002, Israel.,The Paul Feder Laboratory on Alzheimer's Disease Research, Bar-Ilan University, Ramat Gan 5290002, Israel
| | - Gal Yadid
- The Leslie & Susan Gonda Multidisciplinary Brain Research Center, Bar-Ilan University, Ramat Gan 5290002, Israel.,The Mina & Everard Goodman Faculty of Life sciences, Bar-Ilan University, Ramat Gan 5290002, Israel
| | - Rachela Popovtzer
- Faculty of Engineering & the Institute of Nanotechnology & Advanced Materials, Bar-Ilan University, Ramat Gan 5290002, Israel
| |
Collapse
|
76
|
Thomas SS, Coleman M, Carroll E, Polo E, Meder F, Dawson KA. Locating Reactive Groups on Nanomaterials with Gold Nanoclusters: Toward a Surface Reactive Site Map. LANGMUIR : THE ACS JOURNAL OF SURFACES AND COLLOIDS 2017; 33:5086-5097. [PMID: 28463506 DOI: 10.1021/acs.langmuir.7b00952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
Nanoparticles (NPs) are often functionalized with reactive groups such as amines and thiols for the subsequent conjugation of further molecules, e.g., stabilizing polymers, drugs, and proteins for targeting cells or specific diseases. In addition to the quantitative estimation of the reactive conjugation sites, their molecular positioning and nanoscale arrangement on single nanoparticles become more and more important for the tailored engineering and design of functional nanomaterials. Here, we use maleimide or sulfo-succinimidyl ester-modified 1.4 nm gold nanoclusters (AuNCs) to specifically label reactive thiol and amine groups with sub-2-nm precision on metal oxide and polymeric nanostructures. We confirm the binding of AuNCs by measuring and modeling sedimentation properties using analytical centrifugation, imaging their surface distribution and surface distances by transmission electron microscopy (TEM), and comparing the results to ensemble measurements of numbers of reactive surface groups obtained by common photometric assays. We map thiol and amine groups introduced on silica NPs (SiNPs), titania stars (Ti), silica inverse opals (SiOps), and polystyrene NPs (PS NPs). We show that the method is suitable for mapping local, clustered inhomogeneities of the reactive sites on single SiNPs introduced by masking certain areas during surface functionalization. Mapping precise positions of reactive surface groups is essential to the design and tailored ligation of multifunctional nanomaterials.
Collapse
Affiliation(s)
- Steffi S Thomas
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Matthew Coleman
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Emma Carroll
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Ester Polo
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Fabian Meder
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Kenneth A Dawson
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| |
Collapse
|
77
|
Hristov DR, Ye D, de Araújo JM, Ashcroft C, DiPaolo B, Hart R, Earhart C, Lopez H, Dawson KA. Using single nanoparticle tracking obtained by nanophotonic force microscopy to simultaneously characterize nanoparticle size distribution and nanoparticle-surface interactions. NANOSCALE 2017; 9:4524-4535. [PMID: 28317988 DOI: 10.1039/c6nr09331k] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
Comprehensive characterization of nanomaterials for medical applications is a challenging and complex task due to the multitude of parameters which need to be taken into consideration in a broad range of conditions. Routine methods such as dynamic light scattering or nanoparticle tracking analysis provide some insight into the physicochemical properties of particle dispersions. For nanomedicine applications the information they supply can be of limited use. For this reason, there is a need for new methodologies and instruments that can provide additional data on nanoparticle properties such as their interactions with surfaces. Nanophotonic force microscopy has been shown as a viable method for measuring the force between surfaces and individual particles in the nano-size range. Here we outline a further application of this technique to measure the size of single particles and based on these measurement build the distribution of a sample. We demonstrate its efficacy by comparing the size distribution obtained with nanophotonic force microscopy to established instruments, such as dynamic light scattering and differential centrifugal sedimentation. Our results were in good agreement to those observed with all other instruments. Furthermore, we demonstrate that the methodology developed in this work can be used to study complex particle mixtures and the surface alteration of materials. For all cases studied, we were able to obtain both the size and the interaction potential of the particles with a surface in a single measurement.
Collapse
Affiliation(s)
- Delyan R Hristov
- Center for BioNano Interaction, School of Chemistry, University College Dublin, Belfield, Dublin, Ireland.
| | - Dong Ye
- Center for BioNano Interaction, School of Chemistry, University College Dublin, Belfield, Dublin, Ireland.
| | - Joao Medeiros de Araújo
- Center for BioNano Interaction, School of Chemistry, University College Dublin, Belfield, Dublin, Ireland. and Departamento de Física, Universidade Federal do Rio Grande do Norte, Natal-RN, Brazil
| | | | | | - Robert Hart
- Optofluidics, Inc., Philadelphia, PA 19104, USA
| | | | - Hender Lopez
- Center for BioNano Interaction, School of Chemistry, University College Dublin, Belfield, Dublin, Ireland.
| | - Kenneth A Dawson
- Center for BioNano Interaction, School of Chemistry, University College Dublin, Belfield, Dublin, Ireland.
| |
Collapse
|
78
|
Villaverde G, Nairi V, Baeza A, Vallet-Regí M. Double Sequential Encrypted Targeting Sequence: A New Concept for Bone Cancer Treatment. Chemistry 2017; 23:7174-7179. [DOI: 10.1002/chem.201605947] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2017] [Indexed: 12/24/2022]
Affiliation(s)
- Gonzalo Villaverde
- Depto. Química Inorgánica y Bioinorgánica; Facultad de Farmacia; Universidad Complutense de Madrid. Plaza Ramon y CajaLs/n. Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12 ¡ Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN); Madrid Spain
| | - Valentina Nairi
- Depto. Química Inorgánica y Bioinorgánica; Facultad de Farmacia; Universidad Complutense de Madrid. Plaza Ramon y CajaLs/n. Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12 ¡ Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN); Madrid Spain
| | - Alejandro Baeza
- Depto. Química Inorgánica y Bioinorgánica; Facultad de Farmacia; Universidad Complutense de Madrid. Plaza Ramon y CajaLs/n. Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12 ¡ Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN); Madrid Spain
| | - María Vallet-Regí
- Depto. Química Inorgánica y Bioinorgánica; Facultad de Farmacia; Universidad Complutense de Madrid. Plaza Ramon y CajaLs/n. Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12 ¡ Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN); Madrid Spain
| |
Collapse
|
79
|
Lara S, Alnasser F, Polo E, Garry D, Lo Giudice MC, Hristov DR, Rocks L, Salvati A, Yan Y, Dawson KA. Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles. ACS NANO 2017; 11:1884-1893. [PMID: 28112950 DOI: 10.1021/acsnano.6b07933] [Citation(s) in RCA: 160] [Impact Index Per Article: 22.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Biomolecules adsorbed on nanoparticles are known to confer a biological identity to nanoparticles, mediating the interactions with cells and biological barriers. However, how these molecules are presented on the particle surface in biological milieu remains unclear. The central aim of this study is to identify key protein recognition motifs and link them to specific cell-receptor interactions. Here, we employed an immuno-mapping technique to quantify epitope presentations of two major proteins in the serum corona, low-density lipoprotein and immunoglobulin G. Combining with a purpose-built receptor expression system, we show that both proteins present functional motifs to allow simultaneous recognition by low-density lipoprotein receptor and Fc-gamma receptor I of the corona. Our results suggest that the "labeling" of nanoparticles by biomolecular adsorption processes allows for multiple pathways in biological processes in which they may be "mistaken" for endogenous objects, such as lipoproteins, and exogenous ones, such as viral infections.
Collapse
Affiliation(s)
- Sandra Lara
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Fatima Alnasser
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Ester Polo
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - David Garry
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Maria Cristina Lo Giudice
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Delyan R Hristov
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Louise Rocks
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Anna Salvati
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Yan Yan
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| | - Kenneth A Dawson
- Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin , Belfield, Dublin 4, Ireland
| |
Collapse
|
80
|
Yu Q, Zhang B, Li J, Li M. The design of peptide-grafted graphene oxide targeting the actin cytoskeleton for efficient cancer therapy. Chem Commun (Camb) 2017; 53:11433-11436. [DOI: 10.1039/c7cc06537j] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Graphene oxide (GO) nanosheets grafted with actin targeting and cell penetrating peptides were designed.
Collapse
Affiliation(s)
- Qilin Yu
- Key Laboratory of Molecular Microbiology and Technology
- Ministry of Education
- Department of Microbiology
- College of Life Science
- Nankai University
| | - Bing Zhang
- Key Laboratory of Molecular Microbiology and Technology
- Ministry of Education
- Department of Microbiology
- College of Life Science
- Nankai University
| | - Jianrong Li
- Key Laboratory of Molecular Microbiology and Technology
- Ministry of Education
- Department of Microbiology
- College of Life Science
- Nankai University
| | - Mingchun Li
- Key Laboratory of Molecular Microbiology and Technology
- Ministry of Education
- Department of Microbiology
- College of Life Science
- Nankai University
| |
Collapse
|